Thrivent Financial for Lutherans
TXMD icon

Thrivent Financial for Lutherans’s TherapeuticsMD TXMD Stock Holding History

Thrivent Financial for Lutherans’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,414
Closed -$146K – 2564
2020
Q4 		$146K Buy
+2,414
New +$165K ﹤0.01% 2428

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrivent Financial for Lutherans's TXMD Position: Q1 2021 in Review

Thrivent Financial for Lutherans sold out of TherapeuticsMD (TXMD) in Q1 2021, closing a stake of 2,414 shares — an estimated $146K sold.

Thrivent Financial for Lutherans first reported a position in TXMD in Q4 2020 and held it in 1 quarter. The position peaked at $146K in Q4 2020. 160 funds tracked by Wall St. Rank hold TXMD as of Q1 2021.

  • Thrivent Financial for Lutherans reported no remaining TherapeuticsMD position as of Q1 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 2,414 TherapeuticsMD shares in Q1 2021, an estimated $146K.
  • Thrivent Financial for Lutherans first reported a position in TherapeuticsMD in Q4 2020 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's TherapeuticsMD position peaked at $146K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2021, filed 17 May 2021.